Allied Biotech Corp Statistics
Allied Biotech Corp (1780) Stock Statistics & Valuation Metrics
Total Valuation
Allied Biotech Corp has a market cap or net worth of TWD 2.59B. The enterprise value is TWD 2.03B.
- Market Cap
- TWD 2.59B
- Enterprise Value
- TWD 2.03B
Share Statistics
Allied Biotech Corp has 109,075,170 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 109,075,170
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Allied Biotech Corp’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 4.78%.
- Return on Equity (ROE)
- 0.10
- Return on Assets (ROA)
- 0.06
- Return on Invested Capital (ROIC)
- 4.78%
- Return on Capital Employed (ROCE)
- 0.09
- Revenue Per Employee
- 21.24M
- Profits Per Employee
- 3.24M
- Employee Count
- 40
- Asset Turnover
- 0.41
- Inventory Turnover
- 1.06
Valuation Ratios
The current PE Ratio of Allied Biotech Corp is 8.07. Allied Biotech Corp’s PEG ratio is 0.01.
- PE Ratio
- 8.07
- PS Ratio
- 2.83
- PB Ratio
- 1.53
- Price to FCF
- 15.12
- Price to Operating Cash Flow
- 11.47
- PEG Ratio
- 0.01
Income Statement
In the last 12 months, Allied Biotech Corp had revenue of 849.51M and earned 129.46M in profits. Earnings per share was 1.34.
- Revenue
- 849.51M
- Gross Profit
- 308.61M
- Operating Income
- 120.39M
- Pretax Income
- 164.12M
- Net Income
- 129.46M
- EBITDA
- 242.44M
- Earnings Per Share (EPS)
- 1.34
Cash Flow
In the last 12 months, operating cash flow was 202.53M and capital expenditures -30.87M, giving a free cash flow of 171.66M billion.
- Operating Cash Flow
- 202.53M
- Free Cash Flow
- 171.66M
- Free Cash Flow per Share
- 1.76
Dividends & Yields
Allied Biotech Corp pays an annual dividend of ―, resulting in a dividend yield of 5.26%
- Dividend Per Share
- ―
- Dividend Yield
- 5.26%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 6.61%
- Earnings Yield
- 12.30%
Stock Price Statistics
- Beta
- 0.28
- 52-Week Price Change
- 31.22%
- 50-Day Moving Average
- 24.46
- 200-Day Moving Average
- 25.92
- Relative Strength Index (RSI)
- 40.98
- Average Volume (3m)
- 77.72K
Important Dates
Allied Biotech Corp upcoming earnings date is Nov 12, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Jul 28, 2026
- Next Earnings Date
- Nov 12, 2026
- Ex-Dividend Date
- ―
Financial Position
Allied Biotech Corp as a current ratio of 1.90, with Debt / Equity ratio of 59.41%
- Current Ratio
- 1.90
- Quick Ratio
- 1.26
- Debt to Market Cap
- 0.32
- Net Debt to EBITDA
- -0.23
- Interest Coverage Ratio
- 6.95
Taxes
In the past 12 months, Allied Biotech Corp has paid 34.66M in taxes.
- Income Tax
- 34.66M
- Effective Tax Rate
- 0.21
Enterprise Valuation
Allied Biotech Corp EV to EBITDA ratio is 10.04, with an EV/FCF ratio of 12.73.
- EV to Sales
- 2.39
- EV to EBITDA
- 10.04
- EV to Free Cash Flow
- 12.73
- EV to Operating Cash Flow
- 10.79
Balance Sheet
Allied Biotech Corp has TWD 1.22B in cash and marketable securities with TWD 752.48M in debt, giving a net cash position of TWD 463.77M billion.
- Cash & Marketable Securities
- TWD 1.22B
- Total Debt
- TWD 752.48M
- Net Cash
- TWD 463.77M
- Net Cash Per Share
- TWD 4.25
- Tangible Book Value Per Share
- TWD 15.52
Margins
Gross margin is 39.62%, with operating margin of 14.96%, and net profit margin of 31.19%.
- Gross Margin
- 39.62%
- Operating Margin
- 14.96%
- Pretax Margin
- 39.78%
- Net Profit Margin
- 31.19%
- EBITDA Margin
- 23.75%
- EBIT Margin
- 18.75%
